Global Endocrinology Drugs Market Size study & Forecast, by Therapy Area (Diabetes drugs, HGH, Thyroid hormone disorders, Others), by Distribution Channel (Hospital pharmacies, Retail pharmacies, Online pharmacies), and Regional Analysis, 2023-2030
Global Endocrinology Drugs Market is valued at approximately USD 25084.24 million in 2022 and is anticipated to grow with a healthy growth rate of more than 7.82% over the forecast period 2023-2030. Endocrinology drugs deals with endocrine disorders, which are related to hormone imbalance and dysfunction in the endocrine system. Endocrinology drugs play an important role in providing therapeutic options for patients suffering from the endocrine disorder. The endocrinology drug market is being driven by factors such as Growing clinical trials of endocrinology drugs and rising endocrine disorders such as diabetes and thyroid.
Endocrinology drugs used to treat diabetes include insulin, which is a hormone that helps regulate blood sugar levels, and oral hypoglycemic agents (OHAs) such as metformin, sulfonylureas, and meglitinides. These drugs are designed to lower blood sugar levels and prevent complications associated with diabetes. According to the World health organization 537 million people lining with diabetes in 2021 and projections show this number is rising to 783 million people diabetic by 2045. Thus, rising in endocrine disorders fuels the market growth. In addition, advanced drug development and a growing aging population are creating a lucrative opportunity for market growth. However, Patent expiry on major endocrinology drugs is the major challenge impeding the endocrinology drugs market growth during the forecast years 2023-2030.
The key regions considered for the Global Endocrinology Drugs Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 due to high healthcare expenses and a high level of awareness in public, USA spends around 17.8% of the total GDP on healthcare. Where Asia Pacific is expected to have significant growth owing to factors such as rising disease prevalence, rising healthcare expenditure, a rapidly growing population and Government initiatives.
Major market player included in this report are:
Abbott Laboratories
Acerus Pharmaceuticals Corp.
Hanmi Pharm Co. Ltd.
Oramed Pharmaceuticals Inc.
Pfizer Inc.
F. Hoffmann La Roche Ltd.
GlaxoSmithKline Plc
Biocon Ltd.
Ascendis Pharma AS
Endo International Plc
Recent Developments in the Market:
On February 2022, Biocon announced the acquisition of Viatris’ biosimilar portfolio for USD 3.335 billion. This acquisition strengthened Biocon’s biosimilar product portfolio and improved its revenue generation.
In Aug 2021, The U.S. Food and Drug Administration (FDA) approved an expanded label for Eli Lilly and Company's rapid-acting Endocrinology Drugs, Lyumjev® (Endocrinology Drugs lispro-AABC injection) 100 units/mL indicated to improve glycemic control in adults with type 1 and type 2 diabetes, to include administration via continuous subcutaneous Endocrinology Drugs infusion (CSII) with an Endocrinology Drugs pump.
In July 2021, Semglee, a first-of-its-kind Endocrinology Drugs product made by India’s Biocon, gets United States approval. Semglee, manufactured by Biocon Biologics, a Bengaluru-based pharmaceutical company, is both interchangeable with and biosimilar to Lantus, a long-acting Endocrinology Drugs product already approved in the United States.
Global Endocrinology Drugs Market Report Scope:
Historical Data – 2020 - 2021
Base Year for Estimation – 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered - Therapy Area, Distribution Channel, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Therapy Area:
Diabetes drugs
HGH
Thyroid hormone disorders
Others
By Distribution Channel:
Hospital pharmacies
Retail pharmacies
Online pharmacies
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa
Endocrinology drugs used to treat diabetes include insulin, which is a hormone that helps regulate blood sugar levels, and oral hypoglycemic agents (OHAs) such as metformin, sulfonylureas, and meglitinides. These drugs are designed to lower blood sugar levels and prevent complications associated with diabetes. According to the World health organization 537 million people lining with diabetes in 2021 and projections show this number is rising to 783 million people diabetic by 2045. Thus, rising in endocrine disorders fuels the market growth. In addition, advanced drug development and a growing aging population are creating a lucrative opportunity for market growth. However, Patent expiry on major endocrinology drugs is the major challenge impeding the endocrinology drugs market growth during the forecast years 2023-2030.
The key regions considered for the Global Endocrinology Drugs Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 due to high healthcare expenses and a high level of awareness in public, USA spends around 17.8% of the total GDP on healthcare. Where Asia Pacific is expected to have significant growth owing to factors such as rising disease prevalence, rising healthcare expenditure, a rapidly growing population and Government initiatives.
Major market player included in this report are:
Abbott Laboratories
Acerus Pharmaceuticals Corp.
Hanmi Pharm Co. Ltd.
Oramed Pharmaceuticals Inc.
Pfizer Inc.
F. Hoffmann La Roche Ltd.
GlaxoSmithKline Plc
Biocon Ltd.
Ascendis Pharma AS
Endo International Plc
Recent Developments in the Market:
On February 2022, Biocon announced the acquisition of Viatris’ biosimilar portfolio for USD 3.335 billion. This acquisition strengthened Biocon’s biosimilar product portfolio and improved its revenue generation.
In Aug 2021, The U.S. Food and Drug Administration (FDA) approved an expanded label for Eli Lilly and Company's rapid-acting Endocrinology Drugs, Lyumjev® (Endocrinology Drugs lispro-AABC injection) 100 units/mL indicated to improve glycemic control in adults with type 1 and type 2 diabetes, to include administration via continuous subcutaneous Endocrinology Drugs infusion (CSII) with an Endocrinology Drugs pump.
In July 2021, Semglee, a first-of-its-kind Endocrinology Drugs product made by India’s Biocon, gets United States approval. Semglee, manufactured by Biocon Biologics, a Bengaluru-based pharmaceutical company, is both interchangeable with and biosimilar to Lantus, a long-acting Endocrinology Drugs product already approved in the United States.
Global Endocrinology Drugs Market Report Scope:
Historical Data – 2020 - 2021
Base Year for Estimation – 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered - Therapy Area, Distribution Channel, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Therapy Area:
Diabetes drugs
HGH
Thyroid hormone disorders
Others
By Distribution Channel:
Hospital pharmacies
Retail pharmacies
Online pharmacies
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Million)
1.2.1. Endocrinology Drugs Market, by Region, 2020-2030 (USD Million)
1.2.2. Endocrinology Drugs Market, by Therapy Area, 2020-2030 (USD Million)
1.2.3. Endocrinology Drugs Market, by Distribution Channel , 2020-2030 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL ENDOCRINOLOGY DRUGS MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL ENDOCRINOLOGY DRUGS MARKET DYNAMICS
3.1. Endocrinology Drugs Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Growing clinical trials for development of endocrinology drugs
3.1.1.2. Growing prevalence of endocrine disorder
3.1.2. Market Challenges
3.1.2.1. Expiry of patents
3.1.3. Market Opportunities
3.1.3.1. Advancement in drug development activities
3.1.3.2. Growing aging population
CHAPTER 4. GLOBAL ENDOCRINOLOGY DRUGS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL ENDOCRINOLOGY DRUGS MARKET, BY THERAPY AREA
5.1. Market Snapshot
5.2. Global Endocrinology Drugs Market by Therapy Area, Performance - Potential Analysis
5.3. Global Endocrinology Drugs Market Estimates & Forecasts by Therapy Area 2020-2030 (USD Million)
5.4. Endocrinology Drugs Market, Sub Segment Analysis
5.4.1. Diabetes drug
5.4.2. HGH
5.4.3. Thyroid hormone disorder
5.4.4. Other
CHAPTER 6. GLOBAL ENDOCRINOLOGY DRUGS MARKET, BY DISTRIBUTION CHANNEL
6.1. Market Snapshot
6.2. Global Endocrinology Drugs Market by Distribution Channel, Performance - Potential Analysis
6.3. Global Endocrinology Drugs Market Estimates & Forecasts by Distribution Channel 2020-2030 (USD Million)
6.4. Endocrinology Drugs Market, Sub Segment Analysis
6.4.1. Hospital pharmacies
6.4.2. Retail pharmacies
6.4.3. Online pharmacies
CHAPTER 7. GLOBAL ENDOCRINOLOGY DRUGS MARKET, REGIONAL ANALYSIS
7.1. Top Leading Countries
7.2. Top Emerging Countries
7.3. Endocrinology Drugs Market, Regional Market Snapshot
7.4. North America Endocrinology Drugs Market
7.4.1. U.S. Endocrinology Drugs Market
7.4.1.1. Therapy Area breakdown estimates & forecasts, 2020-2030
7.4.1.2. Distribution ChannelChannel breakdown estimates & forecasts, 2020-2030
7.4.2. Canada Endocrinology Drugs Market
7.5. Europe Endocrinology Drugs Market Snapshot
7.5.1. U.K. Endocrinology Drugs Market
7.5.2. Germany Endocrinology Drugs Market
7.5.3. France Endocrinology Drugs Market
7.5.4. Spain Endocrinology Drugs Market
7.5.5. Italy Endocrinology Drugs Market
7.5.6. Rest of Europe Endocrinology Drugs Market
7.6. Asia-Pacific Endocrinology Drugs Market Snapshot
7.6.1. China Endocrinology Drugs Market
7.6.2. India Endocrinology Drugs Market
7.6.3. Japan Endocrinology Drugs Market
7.6.4. Australia Endocrinology Drugs Market
7.6.5. South Korea Endocrinology Drugs Market
7.6.6. Rest of Asia Pacific Endocrinology Drugs Market
7.7. Latin America Endocrinology Drugs Market Snapshot
7.7.1. Brazil Endocrinology Drugs Market
7.7.2. Mexico Endocrinology Drugs Market
7.8. Middle East & Africa Endocrinology Drugs Market
7.8.1. Saudi Arabia Endocrinology Drugs Market
7.8.2. South Africa Endocrinology Drugs Market
7.8.3. Rest of Middle East & Africa Endocrinology Drugs Market
CHAPTER 8. COMPETITIVE INTELLIGENCE
8.1. Key Company SWOT Analysis
8.1.1. Company
8.1.2. Company
8.1.3. Company
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Abbott Laboratories
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Recent Developments
8.3.2. Acerus Pharmaceuticals corp.
8.3.3. Hanmi Pharm co. Ltd
8.3.4. Oramed Pharmaceuticals
8.3.5. Pfizer Inc.
8.3.6. F. Hoffmann La Roche Ltd.
8.3.7. Glaosmithkline Plc
8.3.8. Biocon Ltd.
8.3.9. Ascendis Pharma AS
8.3.10. Endo Inernational Plc
CHAPTER 9. RESEARCH PROCESS
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Million)
1.2.1. Endocrinology Drugs Market, by Region, 2020-2030 (USD Million)
1.2.2. Endocrinology Drugs Market, by Therapy Area, 2020-2030 (USD Million)
1.2.3. Endocrinology Drugs Market, by Distribution Channel , 2020-2030 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL ENDOCRINOLOGY DRUGS MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL ENDOCRINOLOGY DRUGS MARKET DYNAMICS
3.1. Endocrinology Drugs Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Growing clinical trials for development of endocrinology drugs
3.1.1.2. Growing prevalence of endocrine disorder
3.1.2. Market Challenges
3.1.2.1. Expiry of patents
3.1.3. Market Opportunities
3.1.3.1. Advancement in drug development activities
3.1.3.2. Growing aging population
CHAPTER 4. GLOBAL ENDOCRINOLOGY DRUGS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL ENDOCRINOLOGY DRUGS MARKET, BY THERAPY AREA
5.1. Market Snapshot
5.2. Global Endocrinology Drugs Market by Therapy Area, Performance - Potential Analysis
5.3. Global Endocrinology Drugs Market Estimates & Forecasts by Therapy Area 2020-2030 (USD Million)
5.4. Endocrinology Drugs Market, Sub Segment Analysis
5.4.1. Diabetes drug
5.4.2. HGH
5.4.3. Thyroid hormone disorder
5.4.4. Other
CHAPTER 6. GLOBAL ENDOCRINOLOGY DRUGS MARKET, BY DISTRIBUTION CHANNEL
6.1. Market Snapshot
6.2. Global Endocrinology Drugs Market by Distribution Channel, Performance - Potential Analysis
6.3. Global Endocrinology Drugs Market Estimates & Forecasts by Distribution Channel 2020-2030 (USD Million)
6.4. Endocrinology Drugs Market, Sub Segment Analysis
6.4.1. Hospital pharmacies
6.4.2. Retail pharmacies
6.4.3. Online pharmacies
CHAPTER 7. GLOBAL ENDOCRINOLOGY DRUGS MARKET, REGIONAL ANALYSIS
7.1. Top Leading Countries
7.2. Top Emerging Countries
7.3. Endocrinology Drugs Market, Regional Market Snapshot
7.4. North America Endocrinology Drugs Market
7.4.1. U.S. Endocrinology Drugs Market
7.4.1.1. Therapy Area breakdown estimates & forecasts, 2020-2030
7.4.1.2. Distribution ChannelChannel breakdown estimates & forecasts, 2020-2030
7.4.2. Canada Endocrinology Drugs Market
7.5. Europe Endocrinology Drugs Market Snapshot
7.5.1. U.K. Endocrinology Drugs Market
7.5.2. Germany Endocrinology Drugs Market
7.5.3. France Endocrinology Drugs Market
7.5.4. Spain Endocrinology Drugs Market
7.5.5. Italy Endocrinology Drugs Market
7.5.6. Rest of Europe Endocrinology Drugs Market
7.6. Asia-Pacific Endocrinology Drugs Market Snapshot
7.6.1. China Endocrinology Drugs Market
7.6.2. India Endocrinology Drugs Market
7.6.3. Japan Endocrinology Drugs Market
7.6.4. Australia Endocrinology Drugs Market
7.6.5. South Korea Endocrinology Drugs Market
7.6.6. Rest of Asia Pacific Endocrinology Drugs Market
7.7. Latin America Endocrinology Drugs Market Snapshot
7.7.1. Brazil Endocrinology Drugs Market
7.7.2. Mexico Endocrinology Drugs Market
7.8. Middle East & Africa Endocrinology Drugs Market
7.8.1. Saudi Arabia Endocrinology Drugs Market
7.8.2. South Africa Endocrinology Drugs Market
7.8.3. Rest of Middle East & Africa Endocrinology Drugs Market
CHAPTER 8. COMPETITIVE INTELLIGENCE
8.1. Key Company SWOT Analysis
8.1.1. Company
8.1.2. Company
8.1.3. Company
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Abbott Laboratories
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Recent Developments
8.3.2. Acerus Pharmaceuticals corp.
8.3.3. Hanmi Pharm co. Ltd
8.3.4. Oramed Pharmaceuticals
8.3.5. Pfizer Inc.
8.3.6. F. Hoffmann La Roche Ltd.
8.3.7. Glaosmithkline Plc
8.3.8. Biocon Ltd.
8.3.9. Ascendis Pharma AS
8.3.10. Endo Inernational Plc
CHAPTER 9. RESEARCH PROCESS
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Endocrinology Drugs Market, report scope
TABLE 2. Global Endocrinology Drugs Market estimates & forecasts by Region 2020-2030 (USD Million)
TABLE 3. Global Endocrinology Drugs Market estimates & forecasts by Therapy Area 2020-2030 (USD Million)
TABLE 4. Global Endocrinology Drugs Market estimates & forecasts by Distribution Channel 2020-2030 (USD Million)
TABLE 5. Global Endocrinology Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 6. Global Endocrinology Drugs Market by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 7. Global Endocrinology Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 8. Global Endocrinology Drugs Market by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 9. Global Endocrinology Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 10. Global Endocrinology Drugs Market by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 11. Global Endocrinology Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 12. Global Endocrinology Drugs Market by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 13. Global Endocrinology Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 14. Global Endocrinology Drugs Market by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 15. U.S. Endocrinology Drugs Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 16. U.S. Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 17. U.S. Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 18. Canada Endocrinology Drugs Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 19. Canada Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 20. Canada Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 21. UK Endocrinology Drugs Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 22. UK Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 23. UK Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 24. Germany Endocrinology Drugs Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 25. Germany Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 26. Germany Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 27. France Endocrinology Drugs Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 28. France Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 29. France Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 30. Italy Endocrinology Drugs Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 31. Italy Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 32. Italy Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 33. Spain Endocrinology Drugs Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 34. Spain Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 35. Spain Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 36. RoE Endocrinology Drugs Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 37. RoE Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 38. RoE Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 39. China Endocrinology Drugs Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 40. China Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 41. China Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 42. India Endocrinology Drugs Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 43. India Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 44. India Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 45. Japan Endocrinology Drugs Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 46. Japan Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 47. Japan Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 48. South Korea Endocrinology Drugs Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 49. South Korea Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 50. South Korea Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 51. Australia Endocrinology Drugs Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 52. Australia Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 53. Australia Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 54. RoAPAC Endocrinology Drugs Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 55. RoAPAC Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 56. RoAPAC Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 57. Brazil Endocrinology Drugs Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 58. Brazil Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 59. Brazil Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 60. Mexico Endocrinology Drugs Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 61. Mexico Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 62. Mexico Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 63. RoLA Endocrinology Drugs Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 64. RoLA Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 65. RoLA Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 66. Saudi Arabia Endocrinology Drugs Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 67. South Africa Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 68. RoMEA Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 69. List of secondary sources, used in the study of global Endocrinology Drugs Market
TABLE 70. List of primary sources, used in the study of global Endocrinology Drugs Market
TABLE 71. Years considered for the study
TABLE 72. Exchange rates considered
List of tables and figures are dummy in nature, final lists may vary in the final deliverable
TABLE 1. Global Endocrinology Drugs Market, report scope
TABLE 2. Global Endocrinology Drugs Market estimates & forecasts by Region 2020-2030 (USD Million)
TABLE 3. Global Endocrinology Drugs Market estimates & forecasts by Therapy Area 2020-2030 (USD Million)
TABLE 4. Global Endocrinology Drugs Market estimates & forecasts by Distribution Channel 2020-2030 (USD Million)
TABLE 5. Global Endocrinology Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 6. Global Endocrinology Drugs Market by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 7. Global Endocrinology Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 8. Global Endocrinology Drugs Market by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 9. Global Endocrinology Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 10. Global Endocrinology Drugs Market by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 11. Global Endocrinology Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 12. Global Endocrinology Drugs Market by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 13. Global Endocrinology Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Million)
TABLE 14. Global Endocrinology Drugs Market by region, estimates & forecasts, 2020-2030 (USD Million)
TABLE 15. U.S. Endocrinology Drugs Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 16. U.S. Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 17. U.S. Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 18. Canada Endocrinology Drugs Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 19. Canada Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 20. Canada Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 21. UK Endocrinology Drugs Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 22. UK Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 23. UK Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 24. Germany Endocrinology Drugs Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 25. Germany Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 26. Germany Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 27. France Endocrinology Drugs Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 28. France Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 29. France Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 30. Italy Endocrinology Drugs Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 31. Italy Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 32. Italy Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 33. Spain Endocrinology Drugs Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 34. Spain Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 35. Spain Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 36. RoE Endocrinology Drugs Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 37. RoE Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 38. RoE Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 39. China Endocrinology Drugs Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 40. China Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 41. China Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 42. India Endocrinology Drugs Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 43. India Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 44. India Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 45. Japan Endocrinology Drugs Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 46. Japan Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 47. Japan Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 48. South Korea Endocrinology Drugs Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 49. South Korea Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 50. South Korea Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 51. Australia Endocrinology Drugs Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 52. Australia Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 53. Australia Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 54. RoAPAC Endocrinology Drugs Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 55. RoAPAC Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 56. RoAPAC Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 57. Brazil Endocrinology Drugs Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 58. Brazil Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 59. Brazil Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 60. Mexico Endocrinology Drugs Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 61. Mexico Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 62. Mexico Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 63. RoLA Endocrinology Drugs Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 64. RoLA Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 65. RoLA Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 66. Saudi Arabia Endocrinology Drugs Market estimates & forecasts, 2020-2030 (USD Million)
TABLE 67. South Africa Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 68. RoMEA Endocrinology Drugs Market estimates & forecasts by segment 2020-2030 (USD Million)
TABLE 69. List of secondary sources, used in the study of global Endocrinology Drugs Market
TABLE 70. List of primary sources, used in the study of global Endocrinology Drugs Market
TABLE 71. Years considered for the study
TABLE 72. Exchange rates considered
List of tables and figures are dummy in nature, final lists may vary in the final deliverable
LIST OF FIGURES
FIG 1. Global Endocrinology Drugs Market, research methodology
FIG 2. Global Endocrinology Drugs Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Endocrinology Drugs Market, key trends 2022
FIG 5. Global Endocrinology Drugs Market, growth prospects 2023-2030
FIG 6. Global Endocrinology Drugs Market, porters 5 force model
FIG 7. Global Endocrinology Drugs Market, pest analysis
FIG 8. Global Endocrinology Drugs Market, value chain analysis
FIG 9. Global Endocrinology Drugs Market by segment, 2020 & 2030 (USD Million)
FIG 10. Global Endocrinology Drugs Market by segment, 2020 & 2030 (USD Million)
FIG 11. Global Endocrinology Drugs Market by segment, 2020 & 2030 (USD Million)
FIG 12. Global Endocrinology Drugs Market by segment, 2020 & 2030 (USD Million)
FIG 13. Global Endocrinology Drugs Market by segment, 2020 & 2030 (USD Million)
FIG 14. Global Endocrinology Drugs Market, regional snapshot 2020 & 2030
FIG 15. North America Endocrinology Drugs Market 2020 & 2030 (USD Million)
FIG 16. Europe Endocrinology Drugs Market 2020 & 2030 (USD Million)
FIG 17. Asia pacific Endocrinology Drugs Market 2020 & 2030 (USD Million)
FIG 18. Latin America Endocrinology Drugs Market 2020 & 2030 (USD Million)
FIG 19. Middle East & Africa Endocrinology Drugs Market 2020 & 2030 (USD Million)
List of tables and figures are dummy in nature, final lists may vary in the final deliverable
FIG 1. Global Endocrinology Drugs Market, research methodology
FIG 2. Global Endocrinology Drugs Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Endocrinology Drugs Market, key trends 2022
FIG 5. Global Endocrinology Drugs Market, growth prospects 2023-2030
FIG 6. Global Endocrinology Drugs Market, porters 5 force model
FIG 7. Global Endocrinology Drugs Market, pest analysis
FIG 8. Global Endocrinology Drugs Market, value chain analysis
FIG 9. Global Endocrinology Drugs Market by segment, 2020 & 2030 (USD Million)
FIG 10. Global Endocrinology Drugs Market by segment, 2020 & 2030 (USD Million)
FIG 11. Global Endocrinology Drugs Market by segment, 2020 & 2030 (USD Million)
FIG 12. Global Endocrinology Drugs Market by segment, 2020 & 2030 (USD Million)
FIG 13. Global Endocrinology Drugs Market by segment, 2020 & 2030 (USD Million)
FIG 14. Global Endocrinology Drugs Market, regional snapshot 2020 & 2030
FIG 15. North America Endocrinology Drugs Market 2020 & 2030 (USD Million)
FIG 16. Europe Endocrinology Drugs Market 2020 & 2030 (USD Million)
FIG 17. Asia pacific Endocrinology Drugs Market 2020 & 2030 (USD Million)
FIG 18. Latin America Endocrinology Drugs Market 2020 & 2030 (USD Million)
FIG 19. Middle East & Africa Endocrinology Drugs Market 2020 & 2030 (USD Million)
List of tables and figures are dummy in nature, final lists may vary in the final deliverable
